SFC has been engaging in R&D on fundamental materials since 2014, after establishing a strategy and vision
based on thorough analysis and cool-headed perception of the reality. Our achievements have been adopted
in several mass-produced molecular diagnostics kits such as COVID-19 PCR kits so that we earned a market recognition and consolidating its position as a key driver for the continuing growth of SFC.
SFC will do its best to be positioned as a global player, beyond the first in Korea, by continuously bolstering
the capability for R&D and manufacturing, as well as enhancing network with many partners from more diverse fields
including diagnostics and pharmaceutical industries.